Eight of the top 20 biopharmas standardize on
Vault EDC to build a modern clinical data foundation
BARCELONA, Spain, March 20, 2024 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that Veeva Vault EDC powered more than
1,000 study starts. The increased adoption of Vault EDC is enabling
companies to establish a foundation for modern electronic data
capture (EDC), including eight of the top 20 biopharmas and two of
the top six CROs standardizing on Vault EDC. This underscores the
ongoing shift to advanced clinical data management, with one top 20
biopharma recently migrating 25 studies and more organizations
switching to Vault EDC for greater efficiency and speed.
"Veeva Vault EDC simplifies complex data management for faster
study builds and streamlined processes," said Richard Young, vice president, clinical data
strategy at Veeva. "Research sites, sponsors, and CROs are reducing
effort by 50% and executing 50% faster with Vault EDC,
significantly advancing clinical data management for the benefit of
the industry."
Clinical teams are using Vault EDC to build studies faster. With
industry-leading capabilities, Vault EDC offers a drag-and-drop
interface and eliminates the need for custom programming. This
makes it easier to design patient forms and perform edit checks,
saving time and effort. The increased flexibility allows companies
to run the study they need, even for complex multi-arm adaptive
trials.
Vault EDC is part of Veeva Vault Clinical Data Management,
bringing together EDC and Veeva Clinical Database (CDB) for
next-generation clinical data management. Learn how companies are
accelerating trial processes with Vault EDC at Veeva R&D and
Quality Summit, Europe. Life
sciences industry professionals can register for the 4-5
June event in Madrid.
What the industry is saying about Veeva Vault EDC
"At Boehringer Ingelheim, one key strategic imperative is
to own both clinical and operational data," said Uli Broedl, senior
vice president and global head, clinical development and
operations at Boehringer Ingelheim. "By bringing together data
and processes across clinical and related functions on a single
cloud platform, we look to establish a connected technology
landscape for agile collaboration that can accelerate the
development of innovative medicines."
"Veeva Vault EDC delivers a better user experience for sites,
streamlining critical processes so we can focus on patient care,"
said Dr. Viviënne van de Walle, principal investigator, medical
director at PT&R. "With Vault EDC, sponsors generate documents
upon closing the trial and seamlessly share with site staff to
accept and acknowledge, accelerating study close-out."
"Using Veeva Vault EDC, we now complete user acceptance testing
in nearly half the time," said Paula
Bain, president, clinical development services at Syneos
Health. "With faster and more efficient data management processes,
we are advancing our operations to move from data checks to data
science."
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-Q for the period ended October 31, 2023, which you can
find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
|
|
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
|
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/veeva-vault-edc-surpasses-1-000-study-start-milestone-302093621.html